New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III

Authors: Nicola Battelli, Carmela Mocerino, Michele Montedoro, Mirco Pistelli, Ilaria Portarena, Mario Rosanova, Tina Sidoni, Patrizia Vici

Source: Current Oncology, Vol 32, Iss 4, p 192 (2025)

Subject Terms: breast cancer, adjuvant therapy, ribociclib, stage II, stage III, adherence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.mdpi.com/1718-7729/32/4/192; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

Access URL: https://doaj.org/article/b8e1b97e1d2b4e92934034963da8e5e3

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.

Authors: Amelia Buffone, Carlo Capalbo, Enrico Ricevuto, Tina Sidoni, Laura Ottini, Mario Falchetti, Enrico Cortesi, Giovanni Scambia, Silverio Tomao, Christian Rinaldi, Massimo Zani, Sergio Ferraro, Isabella Screpanti, Giuseppe Giannini

Source: Breast Cancer Research & Treatment; Dec2007, Vol. 106 Issue 2, p289-296, 8p

Subject Terms: CANCER genetics, BREAST cancer, OVARIAN cancer, GENETIC mutation